I do recall at one point, probably two years ago or more maybe that the TGA knocked back the approval in Australia for reimbursement but I can't remember the reasons given at the time, but I thought it was related to how the application for approval was presented, but too long ago to be certain. There would be similar obstacles for any of the new tests becoming available for sale in Australia at an affordable price. Maybe the Endo test will be that good and reduce the diagnosis time and with that reduce the time for obtaining treatment that people will pay the full price anyway, but PIQ will still need to get the appropriate approvals to sell the tests in any case, which at this point I am unsure as to whether they have them.
PIQ Price at posting:
45.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)